{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:33:36Z","timestamp":1753875216851,"version":"3.41.2"},"reference-count":33,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/07853890.2024.2440631","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:26:31Z","timestamp":1734161191000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Haematologic outcomes and associated clinical characteristics among patients receiving Olaparib therapy in the UAE: a retrospective chart review"],"prefix":"10.1080","volume":"57","author":[{"given":"Lina","family":"Wahba","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Tawam Hospital, Abu Dhabi Health Services Company, Al Ain, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Nabil","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Kendakji","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1331-6664","authenticated-orcid":false,"given":"Sham","family":"ZainAlAbdin","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-3914","authenticated-orcid":false,"given":"Salahdein","family":"Aburuz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"},{"name":"School of Medicine and Health Sciences, George Washington University, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2789-8514","authenticated-orcid":false,"given":"Amal","family":"Akour","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE"},{"name":"Department of Biopharmaceutics and Clinical Pharmacy, The School of Pharmacy, The University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.334516.119"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2020.10.002"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215305"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2728"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163888"},{"key":"e_1_3_5_7_1","volume-title":"Goodman & Gilman\u2019s: the pharmacological basis of therapeutics","author":"Wellstein A","year":"2023","unstructured":"Wellstein A, Giaccone G. Protein kinase inhibitors and pathway-targeted small molecules. In: Brunton LL, Knollmann BC, editors. Goodman & Gilman\u2019s: the pharmacological basis of therapeutics. 14th ed. [Internet]. New York (NY): McGraw-Hill Education; 2023 [cited 2024 May 21]. Available from: http:\/\/accesspharmacy.mhmedical.com\/content.aspx?aid=1193242501","edition":"14"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105535"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S169558"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0268"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1045875"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S147726"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.06.012"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13584"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390876"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220940043"},{"key":"e_1_3_5_18_1","unstructured":"Dosing & Management \u2013 LYNPARZA\u00ae (olaparib) for metastatic pancreatic cancer; 2024 [Internet] [cited 2024 May 22]. Available from: https:\/\/www.lynparzahcp.com\/pancreatic-cancer\/dosing.html"},{"key":"e_1_3_5_19_1","unstructured":"ANNEX I; 2024 [Internet] [cited 2024 May 22]. Available from: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2018\/20180508140545\/anx_140545_en.pdf"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01294"},{"key":"e_1_3_5_21_1","unstructured":"Olson N. Olaparib (Lynparza\u00ae) adverse event management. Cazenovia NY: The National Community Oncology Dispensing Association Inc. (NCODA); 2024."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.912256"},{"key":"e_1_3_5_24_1","unstructured":"Medscape. Predicting risk for secondary leukemia after PARPi therapy; 2024 [Internet] [cited 2024 May 22]. Available from: https:\/\/www.medscape.com\/viewarticle\/ovarian-cancer-predicting-risk-secondary-leukemia-after-2024a10005dg"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.07.016"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.5430\/crim.v6n1p1"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034123"},{"key":"e_1_3_5_28_1","doi-asserted-by":"crossref","unstructured":"Kataoka N Hata T Hosomi K et\u00a0al. Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian peritoneal or fallopian tube cancer: a retrospective observational study. J Chemother. 2024;1\u20137. doi: 10.1080\/1120009X.2024.2345025.","DOI":"10.1080\/1120009X.2024.2345025"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1162665"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241248328"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.898150"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16231"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.5603\/rpor.99026"},{"key":"e_1_3_5_34_1","unstructured":"The Lancet: new study reveals global anemia cases remain persistently high among women and children. Anemia rates decline for men. Institute for Health Metrics and Evaluation; 2024 [Internet] [cited 2024 Sep 19]. Available from: https:\/\/www.healthdata.org\/news-events\/newsroom\/news-releases\/lancet-new-study-reveals-global-anemia-cases-remain-persistently"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07853890.2024.2440631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:26:35Z","timestamp":1734161195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07853890.2024.2440631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/07853890.2024.2440631"],"URL":"https:\/\/doi.org\/10.1080\/07853890.2024.2440631","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"type":"print","value":"0785-3890"},{"type":"electronic","value":"1365-2060"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iann20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2440631"}}